BDBM419295 2-[[5-[Difluoro(phenyl)methyl]-7-[(3S)-3-hydroxypyrrolidin-1-yl]triazolo[4,5-d]pyrimidin-3-yl]methyl]benzenesulfonyl fluoride::US10457685, Example 24

SMILES O[C@H]1CCN(C1)c1nc(nc2n(Cc3ccccc3S(F)(=O)=O)nnc12)C(F)(F)c1ccccc1

InChI Key InChIKey=ADHRHPCQANGIMU-INIZCTEOSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419295   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419295(2-[[5-[Difluoro(phenyl)methyl]-7-[(3S)-3-hydroxypy...)
Affinity DataKi:  1.13E+3nMAssay Description:he affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419295(2-[[5-[Difluoro(phenyl)methyl]-7-[(3S)-3-hydroxypy...)
Affinity DataKi:  3.29E+3nMAssay Description:he affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent